DISCLOSURES

As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Dr Twelves – Grants/Research Support: AstraZeneca Pharmaceuticals LP, KuDOS Pharmaceuticals, Pfizer Inc, Roche Laboratories Inc, SuperGen Inc; Consultant and Speakers Bureau: Roche Laboratories Inc

Dr Wolmark – No financial interests or affiliations to disclose

Dr Hochster – Consultant: Genentech BioOncology, Novartis Pharmaceuticals, Sanofi-Aventis

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.